Symposia Abstracts
NS17 - Nuovi bersagli farmacologici nella malattia di Parkinson
ELECTROPHYSIOLOGICAL PROPERTIES OF DOPAMINERGIC NEURONS IN PHYSIOLOGICAL AND PATHOLOGICAL CONDITIONS Berretta ., Ledonne A., Mango D., Guatteo E., Federici M., Krashia P., Nisticò R., Mercuri N. |
NEW INSIGHTS INTO PARKINSON’S DISEASE PATHOGENESIS FROM THE STUDY OF THE SYNAPTIC ALPHA-SYNUCLEIN PROTEOME Bellucci A., Zaltieri M., Grigoletto J., Navarria L., Castrezzati S., Rezzani R., Colivicchi M., DellaCorte L., Spillantini M., Missale C., Spano P. |
LRRK2 KINASE ACTIVITY MODULATES PRESYNAPTIC VESICLE RELEASE Cirnaru M., Belluzzi E., Murru L., Marte A., Gabrielli M., Matteoli M., Passafaro M., Onofri F., Greggio E., Piccoli G. |
HYPERPOLARIZATION-ACTIVATED CURRENT, MIDBRAIN DOPAMINE NEURONS AND PARKINSON’S DISEASE Masi A., Narducci R., Landucci E., Moroni F., Mannaioni G. |
ASSEMBLIES OF GLUTAMATE RECEPTOR SUBUNITS WITHIN THE EXCITATORY SYNAPSE: NEW POSSIBLE TARGET IN PARKINSON'S DISEASE Gardoni F., Zianni E., Mellone M., Stanic J., DiLuca M. |